Kahl BS - Search Results

1

Initial Treatment of Early Stage and Low Tumor Burden Follicular Lymphoma.

Cohen JB, Kahl BS. Cohen JB, et al. Among authors: kahl bs. Hematol Oncol Clin North Am. 2020 Aug;34(4):663-672. doi: 10.1016/j.hoc.2020.02.003. Epub 2020 May 5. Hematol Oncol Clin North Am. 2020. PMID: 32586572 Review.

2

Indolent lymphomas: current and emerging treatment approaches.

Maloney D, Kahl BS, Dreyling M. Maloney D, et al. Among authors: kahl bs. Clin Adv Hematol Oncol. 2006 Sep;4(9 Suppl 20):1-10; quiz 11-2. Clin Adv Hematol Oncol. 2006. PMID: 17139243

3

Follicular lymphoma: emerging therapeutic strategies.

Kenkre VP, Kahl BS. Kenkre VP, et al. Among authors: kahl bs. Expert Rev Hematol. 2010 Aug;3(4):485-95. doi: 10.1586/ehm.10.45. Expert Rev Hematol. 2010. PMID: 21083037 Review.

4

What is the best initial therapy for a patient with symptomatic low-grade follicular lymphoma?

Kenkre VP, Kahl BS. Kenkre VP, et al. Among authors: kahl bs. Cancer J. 2012 Sep-Oct;18(5):383-9. doi: 10.1097/PPO.0b013e31826aed6d. Cancer J. 2012. PMID: 23006941 Review.

5

Rituximab extended schedule or re-treatment trial for low-tumor burden follicular lymphoma: eastern cooperative oncology group protocol e4402.

Kahl BS, Hong F, Williams ME, Gascoyne RD, Wagner LI, Krauss JC, Habermann TM, Swinnen LJ, Schuster SJ, Peterson CG, Sborov MD, Martin SE, Weiss M, Ehmann WC, Horning SJ. Kahl BS, et al. J Clin Oncol. 2014 Oct 1;32(28):3096-102. doi: 10.1200/JCO.2014.56.5853. Epub 2014 Aug 25. J Clin Oncol. 2014. PMID: 25154829 Free PMC article. Clinical Trial.

6

Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network study.

Rajguru S, Kristinsdottir T, Eickhoff J, Peterson C, Meyer CM, Traynor AM, Kahl BS. Rajguru S, et al. Among authors: kahl bs. Clin Adv Hematol Oncol. 2014 Aug;12(8):509-15. Clin Adv Hematol Oncol. 2014. PMID: 25356575

7

Fc Gamma Receptor 3A and 2A Polymorphisms Do Not Predict Response to Rituximab in Follicular Lymphoma.

Kenkre VP, Hong F, Cerhan JR, Lewis M, Sullivan L, Williams ME, Gascoyne RD, Horning SJ, Kahl BS. Kenkre VP, et al. Among authors: kahl bs. Clin Cancer Res. 2016 Feb 15;22(4):821-6. doi: 10.1158/1078-0432.CCR-15-1848. Epub 2015 Oct 28. Clin Cancer Res. 2016. PMID: 26510856 Free PMC article.

8

Follicular lymphoma: evolving therapeutic strategies.

Kahl BS, Yang DT. Kahl BS, et al. Blood. 2016 Apr 28;127(17):2055-63. doi: 10.1182/blood-2015-11-624288. Epub 2016 Mar 17. Blood. 2016. PMID: 26989204 Free article. Review.

9

Current treatment approaches in follicular lymphoma.

Kahl BS. Kahl BS. Clin Adv Hematol Oncol. 2015 Nov;13(11):740-3. Clin Adv Hematol Oncol. 2015. PMID: 27058700 Review. No abstract available.

10

US Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.

Press OW, Li H, Schöder H, Straus DJ, Moskowitz CH, LeBlanc M, Rimsza LM, Bartlett NL, Evens AM, Mittra ES, LaCasce AS, Sweetenham JW, Barr PM, Fanale MA, Knopp MV, Noy A, Hsi ED, Cook JR, Lechowicz MJ, Gascoyne RD, Leonard JP, Kahl BS, Cheson BD, Fisher RI, Friedberg JW. Press OW, et al. Among authors: kahl bs. J Clin Oncol. 2016 Jun 10;34(17):2020-7. doi: 10.1200/JCO.2015.63.1119. Epub 2016 Apr 11. J Clin Oncol. 2016. PMID: 27069074 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters